Dr. Hussein Tawbi on Efficacy and Safety Results From the CheckMate 204 Melanoma Trial

Source: Cancer Network, July 2019

Cancer Network spoke with Hussein Tawbi, MD, PhD, of MD Anderson Cancer Center, about the efficacy and safety of the combination of nivolumab plus ipilimumb in patients with symptomatic melanoma brain metastases.